Janel Corporation Reports 5.2% Revenue Growth to $49.1 Million in Latest Quarter

Janel Corporation reported significant financial improvements in its latest quarterly filing, with consolidated revenues reaching $49.1 million for the three months ended June 30, 2025, a 5.2% increase from $46.7 million in the same period last year. For the nine months ended June 30, 2025, revenues totaled $151.2 million, marking a 16.4% increase compared to $129.9 million in the prior year. The company attributed this growth primarily to its Logistics and Life Sciences segments, which saw increased demand and higher freight rates.

Net income for the quarter was $887, or $0.74 per diluted share, a notable recovery from a net loss of $191, or $(0.16) per diluted share, in the same quarter of 2024. For the nine-month period, net income rose to $2.99 million, or $2.48 per diluted share, compared to $304, or $0.25 per diluted share, in the previous year. The increase in profitability was largely driven by improved performance in the Logistics segment, which reported a 6.3% revenue increase for the quarter and a 19.1% increase for the nine months.

Strategically, Janel Corporation has been active in expanding its business through acquisitions. In June 2025, the company acquired 80% of Biosensis Pty Ltd, a developer and manufacturer of antibodies and cell culture media, for an aggregate purchase price of $5.1 million. This acquisition is expected to enhance Janel's offerings in the Life Sciences segment. Additionally, the company completed the acquisition of Airschott, a freight forwarder, in June 2024, which has contributed to its revenue growth.

Operationally, Janel's Logistics segment reported revenues of $43.2 million for the quarter, up from $40.7 million a year earlier, while the Life Sciences segment generated $3.5 million in revenue, reflecting an 8.8% increase. The Manufacturing segment, however, experienced a decline, with revenues falling to $2.4 million from $2.8 million due to timing issues with larger orders. The company also reported a net cash increase from operating activities of $17.6 million for the nine months ended June 30, 2025, compared to $6.4 million in the prior year.

Looking ahead, Janel Corporation remains focused on organic growth and strategic acquisitions to enhance its market position. The company plans to continue investing in its subsidiaries and expanding its service offerings, particularly in the Logistics and Life Sciences segments, to drive future profitability. Management expressed confidence in the company's ability to navigate market conditions and capitalize on growth opportunities.